FDA Approves First Gene Therapy, Kymriah, for Use in U.S.
WEDNESDAY, Aug. 30, 2017 -- The U.S. Food and Drug Administration broke new ground in cancer care Wednesday by approving the first gene therapy for patients in the United States.
Kymriah (tisagenlecleucel) genetically tweaks a patient ' s own immune...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
More News: Cancer | Cancer & Oncology | Food and Drug Administration (FDA) | Gene Therapy | General Medicine | Genetics | USA Health